KMDA (Kamada Ltd) Stock Analysis - Financials

Kamada Ltd (KMDA) is a publicly traded Healthcare sector company. As of May 21, 2026, KMDA trades at $7.87 with a market cap of $451.68M and a P/E ratio of 0.00. KMDA moved +3.62% today. Year to date, KMDA is +8.70%; over the trailing twelve months it is +14.56%. Its 52-week range spans $5.17 to $9.35. Analyst consensus is buy with an average price target of $13.00. Rallies surfaces KMDA's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

What are KMDA's key financials?

KMDA financials on Rallies include revenue, net income, EPS, valuation metrics, market cap, price history, and balance sheet context. KMDA recently traded at $7.87. Market cap is $451.68M. P/E ratio is 0.00. Revenue is $0.

KMDA Key Metrics

Key financial metrics for KMDA
MetricValue
Price$7.87
Market Cap$451.68M
P/E Ratio0.00
EPS$0.00
Dividend Yield0.25%
52-Week High$9.35
52-Week Low$5.17
Volume0
Avg Volume0
Revenue (TTM)$0
Net Income$0
Gross Margin0.00%

Latest KMDA News

KMDA Analyst Consensus

1 analysts cover KMDA: 0 strong buy, 1 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is buy. Average price target: $13.00.

Common questions about KMDA

What are KMDA's key financials?
KMDA financials on Rallies include revenue, net income, EPS, valuation metrics, market cap, price history, and balance sheet context. KMDA recently traded at $7.87. Market cap is $451.68M. P/E ratio is 0.00. Revenue is $0.
Is KMDA research on Rallies investment advice?
No. Rallies provides research, data, and educational context for KMDA. It does not provide personalized investment advice.
KMDA

KMDA